INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 66 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2016. The put-call ratio across all filers is 21.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,000 | 0.0% | 5,320 | +18.2% | 0.00% | – |
| Q4 2017 | $3,000 | +200.0% | 4,500 | +336.5% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 1,031 | +58.6% | 0.00% | – |
| Q2 2017 | $2,000 | -60.0% | 650 | -43.0% | 0.00% | – |
| Q1 2017 | $5,000 | 0.0% | 1,140 | 0.0% | 0.00% | – |
| Q4 2016 | $5,000 | – | 1,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|